High Purity Fevipiprant Powder: Oral Active CRTh2 Receptor Antagonist for Asthma and Hair Loss Treatment
Discover the potential of Fevipiprant for respiratory health and hair loss solutions.
Get a Quote & SampleProduct Core Value
Fevipiprant Pure Powder
Fevipiprant, also known as NVP-QAW039, is a highly effective oral active and potent CRTh2 receptor antagonist with significant potential for treating asthma. Its ability to reduce eosinophilic airway inflammation makes it a promising candidate for patients with persistent moderate-to-severe asthma. Beyond respiratory health, Fevipiprant is also being explored for its efficacy in hair loss treatment, showcasing its versatile therapeutic applications.
- Explore the benefits of Fevipiprant pure powder 99% purity for advanced pharmaceutical formulations.
- Understand the mechanism of CRTh2 receptor antagonism in asthma treatment with this potent compound.
- Learn about the potential of oral active Fevipiprant for hair loss solutions and its underlying research.
- Investigate the anti-inflammatory properties of Fevipiprant and its role in managing respiratory conditions.
Advantages Delivered by the Product
Potent CRTh2 Receptor Antagonist
Fevipiprant exhibits high affinity for the human CRTh2 receptor, making it a potent CRTh2 receptor antagonist crucial for developing new asthma treatments.
Oral Active and Well-Tolerated
The oral active nature of Fevipiprant, combined with its favorable safety profile, ensures ease of administration and good tolerability in patients, contributing to its potential use in long-term therapies.
Reduces Eosinophilic Airway Inflammation
Clinical studies suggest Fevipiprant effectively reduces eosinophilic airway inflammation, a key marker in severe asthma, offering a new avenue for managing this condition.
Key Applications
Asthma Treatment
As a potent CRTh2 receptor antagonist, Fevipiprant is investigated for its efficacy in reducing airway inflammation and improving symptoms in asthma patients.
Hair Loss Treatment
Emerging research indicates Fevipiprant's potential as a treatment for hair loss, suggesting its application in dermatological and cosmetic fields.
Inflammation Management
The compound's ability to inhibit PGD2-induced cytokine release highlights its broader anti-inflammatory properties, useful in various inflammatory conditions.
Pharmaceutical Intermediate
Fevipiprant serves as a valuable pharmaceutical intermediate, aiding in the research and development of new drugs targeting inflammatory pathways.